Enterprise Intelligence Group

  Enterprise Intelligence Group
Designs for Performance Improvement 
home news center   Event Profile 
Login
FDA Rejects ImClone's Erbitux
28-Dec-2001        
Business      
General    
     
     
     
ImClone is rejected by the FDA to review its application for the drug Erbitux.
Events Articles Articles Events Entities Entities Events Leaders Leaders Events Resources Resources Events Conflicts Conflicts Events Trends Trends Events Predictions Predictions Events Countries Countries

© 2012 Enterprise Intelligence Group A division of Enterprise Services Corporation All rights reserved